What is Jrsis Health Car's earnings per share (EPS)?

Jrsis Health Car (JRSS) reported diluted earnings per share of $-0.00 for fiscal year 2023. This represents a 88.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Jrsis Health Car Financials

JRSS

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2024 Currency USD FYE December

This page shows Jrsis Health Car (JRSS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI JRSS FY2023 2026-04-22

FY2023 cash generation came from an ultra-light asset base, while subscale operations still left the company short of current obligations.

From FY2022 to FY2023, revenue more than doubled and operating margin improved from -51.3% to -5.5%, showing that a larger sales base absorbed overhead far better. Operating cash flow also turned positive to $517K as capital spending fell to maintenance levels, so cash conversion recovered faster than accounting profit even though liquidity stayed tight.

The balance-sheet strain is mostly near-term, not a heavy debt stack: liabilities of $2.31M slightly exceeded assets of $2.14M, while long-term debt remained minimal. That points to day-to-day funding pressure from working capital and accumulated losses rather than a large scheduled borrowing burden.

FY2023 still reflects a post-reset company: revenue remained below one-tenth of FY2021, while shares outstanding rose from 18.6M to 82.6M. That combination suggests dilution supplied more of the bridge than new debt, which helps explain why the company could have negative equity without carrying much long-term leverage.

Financial Health Signals

Financial Profile 20/100

Based on FY2023 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Jrsis Health Car's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Jrsis Health Car has an operating margin of -5.5%, meaning the company retains $-5 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -51.3% the prior year.

Growth

Jrsis Health Car's revenue surged 159.2% year-over-year to $3.5M, reflecting rapid business expansion. This strong growth earns a score of 0/100.

Leverage

Jrsis Health Car carries a low D/E ratio of -0.18, meaning only $-0.18 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 76/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Jrsis Health Car's current ratio of 0.80 is below the typical benchmark, resulting in a score of 11/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Jrsis Health Car's free cash flow margin of 14.9% results in a low score of 0/100. Capital expenditures of $1K absorb a large share of operating cash flow.

Piotroski F-Score Neutral

6/9

Jrsis Health Car passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-6.39x

For every $1 of reported earnings, Jrsis Health Car generates $-6.39 in operating cash flow ($517K OCF vs -$81K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-3.3x

Jrsis Health Car earns $-3.3 in operating income for every $1 of interest expense (-$189K vs $56K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.5M

YoY+159.2%

5Y CAGR-34.4%

10Y CAGR-2.3%

Jrsis Health Car generated $3.5M in revenue in fiscal year 2023. This represents an increase of 159.2% from the prior year.

EBITDA

-$135K

YoY+80.1%

Jrsis Health Car's EBITDA was -$135K in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 80.1% from the prior year.

Net Income

-$81K

YoY+85.9%

Jrsis Health Car reported -$81K in net income in fiscal year 2023. This represents an increase of 85.9% from the prior year.

EPS (Diluted)

$-0.00

YoY+88.9%

Jrsis Health Car earned $-0.00 per diluted share (EPS) in fiscal year 2023. This represents an increase of 88.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$515K

YoY+128.5%

5Y CAGR-38.6%

10Y CAGR+5.9%

Jrsis Health Car generated $515K in free cash flow in fiscal year 2023, representing cash available after capex. This represents an increase of 128.5% from the prior year.

Cash & Debt

$118K

YoY+101.5%

5Y CAGR-14.4%

10Y CAGR-15.4%

Jrsis Health Car held $118K in cash against $25K in long-term debt as of fiscal year 2023.

Dividends Per Share

N/A

Shares Outstanding

83M

YoY+41.5%

5Y CAGR+40.7%

10Y CAGR+21.3%

Jrsis Health Car had 83M shares outstanding in fiscal year 2023. This represents an increase of 41.5% from the prior year.

Margins & Returns

Gross Margin

14.0%

YoY+40.7pp

10Y CAGR-57.4pp

Jrsis Health Car's gross margin was 14.0% in fiscal year 2023, indicating the percentage of revenue retained after direct costs. This is up 40.7 percentage points from the prior year.

Operating Margin

-5.5%

YoY+45.8pp

5Y CAGR-26.6pp

10Y CAGR-35.7pp

Jrsis Health Car's operating margin was -5.5% in fiscal year 2023, reflecting core business profitability. This is up 45.8 percentage points from the prior year.

Net Margin

-2.3%

YoY+40.8pp

5Y CAGR-9.4pp

10Y CAGR-11.5pp

Jrsis Health Car's net profit margin was -2.3% in fiscal year 2023, showing the share of revenue converted to profit. This is up 40.8 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$189K

YoY-33.1%

Jrsis Health Car invested $189K in research and development in fiscal year 2023. This represents a decrease of 33.1% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$1K

YoY-96.7%

5Y CAGR-78.6%

10Y CAGR-46.0%

Jrsis Health Car invested $1K in capex in fiscal year 2023, funding long-term assets and infrastructure. This represents a decrease of 96.7% from the prior year.

JRSS Income Statement

Metric	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	$3.5M+159.2%	$1.3M-97.0%	$44.4M+24.3%	$35.7M+13.5%	$31.5M+10.8%	$28.4M
Cost of Revenue	$3.0M+76.0%	$1.7M	N/A	N/A	N/A	N/A
Gross Profit	$483K+235.1%	-$358K	N/A	N/A	N/A	N/A
R&D Expenses	$189K-33.1%	$283K	N/A	N/A	N/A	N/A
SG&A Expenses	$336K+18.6%	$283K	N/A	N/A	N/A	N/A
Operating Income	-$189K+72.5%	-$685K-559.7%	-$104K-101.9%	$5.6M+19.8%	$4.7M-22.1%	$6.0M
Interest Expense	$56K-12.8%	$65K-95.3%	$1.4M+21.5%	$1.1M+2.3%	$1.1M-1.9%	$1.1M
Income Tax	$9K	N/A	$1.2M-13.8%	$1.4M+108.2%	$658K-76.2%	$2.8M
Net Income	-$81K+85.9%	-$576K-118.1%	$3.2M-16.7%	$3.8M+331.0%	$888K-55.4%	$2.0M
EPS (Diluted)	$-0.00+88.9%	$-0.01-105.3%	$0.17+16.6%	$0.15+177.1%	$0.05-60.3%	$0.13

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Revenue	$223K-62.7%	$597K+19.4%	$500K-76.7%	$2.2M+332.3%	$497K+47.4%	$337K-29.3%	$477K	N/A
Cost of Revenue	$196K-52.3%	$411K-7.2%	$443K-77.6%	$2.0M+424.4%	$377K+26.7%	$298K-8.5%	$326K	N/A
Gross Profit	$27K-85.6%	$186K+225.2%	$57K-66.7%	$172K+43.2%	$120K+203.2%	$40K-73.8%	$151K	N/A
R&D Expenses	$29K+200.4%	$10K-6.4%	$10K-87.9%	$84K+133.2%	$36K-5.6%	$38K+26.6%	$30K	N/A
SG&A Expenses	$97K-47.8%	$186K+84.4%	$101K-38.2%	$163K+625.4%	$23K-81.0%	$119K+280.4%	$31K	N/A
Operating Income	-$206K-73.7%	-$119K+26.2%	-$161K+15.2%	-$190K-472.2%	$51K+140.1%	-$127K-264.2%	$78K	N/A
Interest Expense	N/A	$16K+34.3%	$12K	N/A	N/A	$14K-29.0%	$20K	N/A
Income Tax	$7-99.8%	$3K	N/A	$918+846.3%	-$123-19.4%	-$103-101.2%	$8K	N/A
Net Income	-$188K-83.7%	-$102K+29.5%	-$145K-169.0%	-$54K-260.3%	$34K+131.8%	-$106K-333.3%	$45K	N/A
EPS (Diluted)	$-0.00-120.0%	$-0.00+50.0%	$-0.00	N/A	$0.00+140.0%	$-0.00-200.0%	$0.00	N/A

JRSS Balance Sheet

Metric	FY23	FY22	FY21	FY20	FY19	FY18
Total Assets	$2.1M+5.1%	$2.0M-97.3%	$75.7M+28.7%	$58.8M+13.9%	$51.6M-1.6%	$52.5M
Current Assets	$1.8M+10.2%	$1.7M-88.0%	$13.9M+76.0%	$7.9M-17.2%	$9.5M-20.6%	$12.0M
Cash & Equivalents	$118K+101.5%	$59K+96.4%	$30K-96.5%	$845K-57.1%	$2.0M+668.6%	$256K
Inventory	$455K-19.0%	$562K-68.3%	$1.8M+21.5%	$1.5M+35.9%	$1.1M-7.8%	$1.2M
Accounts Receivable	$715K+4.6%	$683K-90.9%	$7.5M+71.8%	$4.4M-4.2%	$4.6M-44.2%	$8.2M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.3M+9.3%	$2.1M-95.0%	$42.6M+42.1%	$30.0M+4.6%	$28.6M-5.9%	$30.4M
Current Liabilities	$2.3M+8.2%	$2.1M-88.0%	$17.6M+49.7%	$11.8M+7.7%	$10.9M+52.2%	$7.2M
Long-Term Debt	$25K	N/A	N/A	N/A	N/A	N/A
Total Equity	-$137K-135.1%	-$58K-100.2%	$33.1M+73.9%	$19.0M+28.5%	$14.8M+4.8%	$14.1M
Retained Earnings	-$3.4M-2.4%	-$3.4M-79.1%	-$1.9M+54.3%	-$4.1M+39.5%	-$6.8M-152.6%	$12.9M

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Total Assets	$2.1M-1.9%	$2.1M+0.3%	$2.1M-1.7%	$2.1M+279.8%	$565K-14.6%	$661K-9.3%	$729K-64.3%	$2.0M
Current Assets	$1.8M-2.1%	$1.8M+0.6%	$1.8M-1.0%	$1.8M+247.9%	$527K-14.6%	$618K-8.7%	$676K-59.3%	$1.7M
Cash & Equivalents	$1K-99.7%	$446K+37.8%	$324K+174.0%	$118K+253.8%	$33K+18.3%	$28K+50.3%	$19K-68.0%	$59K
Inventory	$362K-9.1%	$398K-10.7%	$446K-2.1%	$455K	N/A	N/A	N/A	$562K
Accounts Receivable	$575K+3.5%	$556K-7.8%	$603K-15.6%	$715K	N/A	$14K	N/A	$683K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.3M+8.5%	$2.1M-12.0%	$2.4M+4.8%	$2.3M+2434.0%	$91K+31.1%	$69K+87.7%	$37K-98.2%	$2.1M
Current Liabilities	$2.3M+8.9%	$2.1M-11.8%	$2.4M+5.1%	$2.3M+2406.6%	$91K+31.1%	$69K+87.7%	$37K-98.2%	$2.1M
Long-Term Debt	$6K-48.2%	$12K-33.8%	$18K-26.2%	$25K	N/A	N/A	N/A	N/A
Total Equity	-$198K-2569.8%	-$7K+97.2%	-$260K-89.2%	-$137K-129.0%	$474K-20.0%	$592K-14.4%	$692K+1283.7%	-$58K
Retained Earnings	-$3.9M-5.1%	-$3.7M-2.9%	-$3.6M-4.2%	-$3.4M+85.7%	-$24.0M-0.5%	-$23.9M-0.4%	-$23.8M-608.7%	-$3.4M

JRSS Cash Flow Statement

Metric	FY23	FY22	FY21	FY20	FY19	FY18
Operating Cash Flow	$517K+129.3%	-$1.8M-121.4%	$8.2M-22.6%	$10.6M-10.2%	$11.8M+28.8%	$9.2M
Capital Expenditures	$1K-96.7%	$45K-98.1%	$2.3M-72.1%	$8.3M+75.5%	$4.7M+43.8%	$3.3M
Free Cash Flow	$515K+128.5%	-$1.8M-130.5%	$5.9M+150.0%	$2.4M-66.8%	$7.1M+20.5%	$5.9M
Investing Cash Flow	$19K+100.7%	-$2.8M+48.6%	-$5.5M+33.5%	-$8.3M-108.7%	-$4.0M+33.6%	-$6.0M
Financing Cash Flow	-$568K-130.6%	$1.9M+166.4%	-$2.8M+18.4%	-$3.4M+43.9%	-$6.1M-55.7%	-$3.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Operating Cash Flow	-$352K-31.0%	-$269K-31.2%	-$205K-314.0%	$96K+206.4%	-$90K-117.1%	$528K+3295.6%	-$17K+99.7%	-$4.8M
Capital Expenditures	$68K	N/A	N/A	$1K+100.3%	-$359K	N/A	N/A	-$2K
Free Cash Flow	-$420K	N/A	N/A	$95K+121.1%	-$449K	N/A	N/A	-$4.8M
Investing Cash Flow	-$22	N/A	N/A	$19K	N/A	N/A	N/A	$2K
Financing Cash Flow	-$96K-123.8%	$403K-2.6%	$413K+5146.5%	$8K+102.3%	-$350K-320.2%	-$83K+41.9%	-$143K-105.5%	$2.6M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

JRSS Financial Ratios

Metric	FY23	FY22	FY21	FY20	FY19	FY18
Gross Margin	14.0%+40.7pp	-26.8%	N/A	N/A	N/A	N/A
Operating Margin	-5.5%+45.8pp	-51.3%-51.1pp	-0.2%-15.9pp	15.7%+0.8pp	14.8%-6.3pp	21.1%
Net Margin	-2.3%+40.8pp	-43.1%-50.3pp	7.2%-3.5pp	10.7%+7.9pp	2.8%-4.2pp	7.0%
Return on Equity	N/A	N/A	9.6%-10.5pp	20.1%+14.1pp	6.0%-8.1pp	14.1%
Return on Assets	-3.8%+24.4pp	-28.2%-32.4pp	4.2%-2.3pp	6.5%+4.8pp	1.7%-2.1pp	3.8%
Current Ratio	0.80+0.0	0.790.0	0.79+0.1	0.67-0.2	0.87-0.8	1.67
Debt-to-Equity	-0.18+35.9	-36.09-37.4	1.29-0.3	1.57-0.4	1.93-0.2	2.15
FCF Margin	14.9%+150.4pp	-135.5%-148.8pp	13.4%+6.7pp	6.6%-16.0pp	22.7%+1.8pp	20.8%

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Gross Margin	12.1%-19.1pp	31.1%+19.7pp	11.4%+3.4pp	8.0%-16.1pp	24.1%+12.4pp	11.7%-20.0pp	31.7%	N/A
Operating Margin	-92.5%-72.6pp	-19.9%+12.3pp	-32.1%-23.3pp	-8.8%-19.1pp	10.3%+48.0pp	-37.7%-54.0pp	16.3%	N/A
Net Margin	-84.4%-67.3pp	-17.2%+11.9pp	-29.0%-26.5pp	-2.5%-9.3pp	6.8%+38.2pp	-31.4%-40.9pp	9.5%	N/A
Return on Equity	N/A	N/A	N/A	N/A	7.1%+25.0pp	-17.9%-24.5pp	6.6%	N/A
Return on Assets	-9.1%-4.2pp	-4.9%+2.1pp	-6.9%-4.4pp	-2.5%-8.5pp	6.0%+22.0pp	-16.0%-22.3pp	6.2%	N/A
Current Ratio	0.78-0.1	0.86+0.1	0.76-0.0	0.80-5.0	5.79-3.1	8.90-9.4	18.30+17.5	0.79
Debt-to-Equity	-0.03+1.6	-1.65-1.6	-0.07+0.1	-0.18-0.4	0.19+0.1	0.12+0.1	0.05+36.1	-36.09
FCF Margin	-188.4%	N/A	N/A	4.4%+94.6pp	-90.2%	N/A	N/A	N/A

Note: Shareholder equity is negative (-$137K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.80), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

United States Basketball League Inc SPEV

$7.8M

Green River CCRRF

$274K

Photozou Hldgs Inc PTZH

$4.8M

FTI FOODTECH INTL INC FTIDF

$30K

Frequently Asked Questions

What is Jrsis Health Car's annual revenue?

Jrsis Health Car (JRSS) reported $3.5M in total revenue for fiscal year 2023. This represents a 159.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Jrsis Health Car's revenue growing?

Jrsis Health Car (JRSS) revenue grew by 159.2% year-over-year, from $1.3M to $3.5M in fiscal year 2023.

Is Jrsis Health Car profitable?

No, Jrsis Health Car (JRSS) reported a net income of -$81K in fiscal year 2023, with a net profit margin of -2.3%.

What is Jrsis Health Car's EBITDA?

Jrsis Health Car (JRSS) had EBITDA of -$135K in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Jrsis Health Car have?

As of fiscal year 2023, Jrsis Health Car (JRSS) had $118K in cash and equivalents against $25K in long-term debt.

What is Jrsis Health Car's gross margin?

Jrsis Health Car (JRSS) had a gross margin of 14.0% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.

What is Jrsis Health Car's operating margin?

Jrsis Health Car (JRSS) had an operating margin of -5.5% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.

What is Jrsis Health Car's net profit margin?

Jrsis Health Car (JRSS) had a net profit margin of -2.3% in fiscal year 2023, representing the share of revenue converted into profit after all expenses.

What is Jrsis Health Car's free cash flow?

Jrsis Health Car (JRSS) generated $515K in free cash flow during fiscal year 2023. This represents a 128.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Jrsis Health Car's operating cash flow?

Jrsis Health Car (JRSS) generated $517K in operating cash flow during fiscal year 2023, representing cash generated from core business activities.

What are Jrsis Health Car's total assets?

Jrsis Health Car (JRSS) had $2.1M in total assets as of fiscal year 2023, including both current and long-term assets.

What are Jrsis Health Car's capital expenditures?

Jrsis Health Car (JRSS) invested $1K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.

How much does Jrsis Health Car spend on research and development?

Jrsis Health Car (JRSS) invested $189K in research and development during fiscal year 2023.

How many shares does Jrsis Health Car have outstanding?

Jrsis Health Car (JRSS) had 83M shares outstanding as of fiscal year 2023.

What is Jrsis Health Car's current ratio?

Jrsis Health Car (JRSS) had a current ratio of 0.80 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.

What is Jrsis Health Car's debt-to-equity ratio?

Jrsis Health Car (JRSS) had a debt-to-equity ratio of -0.18 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Jrsis Health Car's return on assets (ROA)?

Jrsis Health Car (JRSS) had a return on assets of -3.8% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

Why is Jrsis Health Car's debt-to-equity ratio negative or unusual?

Jrsis Health Car (JRSS) has negative shareholder equity of -$137K as of fiscal year 2023, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Jrsis Health Car's Piotroski F-Score?

Jrsis Health Car (JRSS) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Jrsis Health Car's earnings high quality?

Jrsis Health Car (JRSS) has an earnings quality ratio of -6.39x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Jrsis Health Car cover its interest payments?

Jrsis Health Car (JRSS) has an interest coverage ratio of -3.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Jrsis Health Car?

Jrsis Health Car (JRSS) scores 20 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.